CRISPRMED26
The 3rd CRISPR MEDiCiNE Conference, April 13-16th, 2026

CRISPRMED27 - Stay updated

The 3rd CRISPR MEDiCiNE Conference, April 14-16th, 2026 (CRISPRMED26)

CRISPRMED26 - Advancing Medicine for Rare Diseases With Gene Editors

  • Meet the global CRISPR Medicine community in Copenhagen, Denmark April 14-16th, 2026.
  • The world´s largest CRISPR Medicine Conference including all types of modalities used for the development of the next gene- /cell-based medicine.
  • 2 tracks:
    • 1) Functional Genomics (screening platforms, target identification, target validation).
    • 2) Therapeutics (immunotherapies, new modalities, AI, delivery, safety/off-target, pre-clinical/clinical, standards and regulations).
  • Segments: University, Hospital, Biotech, Pharma, CRO, Regulatory, Standards, Legal, Investors, Disease Organisations.
  • Scientific conference: 500 delegates, 70 speakers, 150 poster presenters, 2x poster sessions, 35 sponsors, relevant workshops, social and networking events.
  • Founders´ Breakfast: Exclusive event for founders, investors and business development teams.
  • CRISPRMED26 Satellite Meetings exclusively for CRISPRMED26 attendees:
    • EU Regulatory Requirements (CMC, pre-clinical, clinical)
    • EU CRISPR Screening and Editing Facilities Forum
    • Access, IP Landscape & FTO
  • Young researcher events at the conference: Workshops (organised by GHD), Meet & Match, Meet the Experts, WeDoCRISPR Flash Talk...
  • Official launch of the European Genomic Medicine Consortium (EGMEDC)
  • Opportunity to meet the first CRISPR medicine patients.
  • 35 sponsorship packages will be available.
  • Organiser: CRISPR Medicine News, CMN.

Supporters: Copenhagen Capacity, Innovation District Copenhagen, Copenhagen Legacy Lab

Check out CRISPRMED24 / CRISPRMED25 for inspiration and CMN LinkedIn for the stories.

Stay updated about next CRISPRMED Event - CRISPRMED27 Newsletter.

CRISPRMED26 Scientific Committee
  • Özcan Met, PhD, Ass. Prof. and Head of Cell Therapy Unit and DTU HealthTech, CCIT-DK / DTU, Denmark
  • Jakob Nilsson, Prof. and Groupleader (DK Functional Genomics Screening Unit), Danish Cancer Institute, Denmark
  • Cecilia Jimenez-Mallebrera, PhD and Research Director, Institut de Recerca Sant Joan de Déu. Hospital Sant Joan de Déu Barcelona and CIBERER, Spain
  • Laura Torella, Postdoc, AZ, Sweden
  • Alessia Cavazza, Ass. Prof. and Groupleader, Zayed Centre for Research into Rare Diseases in Children, UCL Great Ormond Street Institute of Child Health, University College London, UK
CRISPRMED26 Supporters

 

 

CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
CRISPRMED26 Supporters
close
Search CRISPR Medicine